HOXB5 Overexpression Is Associated with Neuroendocrine Differentiation and Poor Prognosis in Prostate Cancer
Yohei Sekino(Hiroshima University), Jun Teishima(Hiroshima University)
Cited by 9
Related Papers
KIFC1 Inhibitor CW069 Induces Apoptosis and Reverses Resistance to Docetaxel in Prostate Cancer
|Journal of Clinical Medicine|2019|55
PTEN Is Involved in Sunitinib and Sorafenib Resistance in Renal Cell Carcinoma
|Anticancer Research|2020|31
CD44 Is Involved in Sunitinib Resistance and Poor Progression-free Survival After Sunitinib Treatment of Renal Cell Carcinoma
|Anticancer Research|2021|13
P53 Is Involved in Sunitinib Resistance and Poor Progression-free Survival After Sunitinib Treatment of Renal Cell Carcinoma
|Anticancer Research|2021|10
KIFC1 inhibitor CW069 induces apoptosis and reverses resistance to docetaxel in prostate cancer
|European Urology Supplements|2019|0